SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
10-Q	Quarterly report which provides a continuing view of a company's financial position	Apr 30, 2004	View HTML 0001104659-04-012065.pdf 0001104659-04-012065.rtf 0001104659-04-012065.xls
4/A	Amendment to a previously filed 4	Apr 28, 2004	View HTML 0001179110-04-008957.pdf 0001179110-04-008957.rtf 0001179110-04-008957.xls
4	Statement of changes in beneficial ownership of securities	Apr 28, 2004	View HTML 0001179110-04-008995.pdf 0001179110-04-008995.rtf 0001179110-04-008995.xls
4/A	Amendment to a previously filed 4	Apr 27, 2004	View HTML 0001179110-04-008889.pdf 0001179110-04-008889.rtf 0001179110-04-008889.xls
8-K	Report of unscheduled material events or corporate event	Apr 21, 2004	View HTML 0001157523-04-003503.pdf 0001157523-04-003503.rtf
DEFR14A	DEFR14A	Apr 19, 2004	View HTML 0001206774-04-000346.pdf 0001206774-04-000346.rtf 0001206774-04-000346.xls
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Apr 12, 2004	View HTML 0001145443-04-000574.pdf 0001145443-04-000574.rtf 0001145443-04-000574.xls
10-K	Annual report which provides a comprehensive overview of the company for the past year	Mar 15, 2004	View HTML 0001047469-04-007780.pdf 0001047469-04-007780.rtf 0001047469-04-007780.xls
4	Statement of changes in beneficial ownership of securities	Mar 12, 2004	View HTML 0001179110-04-005879.pdf 0001179110-04-005879.rtf 0001179110-04-005879.xls
4	Statement of changes in beneficial ownership of securities	Mar 4, 2004	View HTML 0001179110-04-005299.pdf 0001179110-04-005299.rtf 0001179110-04-005299.xls

Data provided by Kaleidoscope.